A critical advance in cancer research is emerging with the use of VHH fragments to re-engage dysfunctional p53. This crucial malignant protector protein is frequently lost in several forms of tumors, causing https://thebookmarkid.com/story22065067/mini-antibodies-reactivate-the-p53-protein-a-potential-pathway-for-tumor-therapy